These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 28641792)

  • 21. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.
    Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ
    JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
    Pokorney SD; Al-Khatib SM; Sun JL; Schulte P; O'Connor CM; Teerlink JR; Armstrong PW; Ezekowitz JA; Starling RC; Voors AA; Velazquez EJ; Hernandez AF; Mentz RJ
    Eur J Heart Fail; 2018 Mar; 20(3):525-532. PubMed ID: 29266564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
    Mentz RJ; Hernandez AF; Stebbins A; Ezekowitz JA; Felker GM; Heizer GM; Atar D; Teerlink JR; Califf RM; Massie BM; Hasselblad V; Starling RC; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2013 Apr; 15(4):456-64. PubMed ID: 23159547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
    Fudim M; O'Connor CM; Dunning A; Ambrosy AP; Armstrong PW; Coles A; Ezekowitz JA; Greene SJ; Metra M; Starling RC; Voors AA; Hernandez AF; Michael Felker G; Mentz RJ
    Eur J Heart Fail; 2018 Feb; 20(2):304-314. PubMed ID: 29082629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH;
    Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.
    Greene SJ; Hernandez AF; Sun JL; Butler J; Armstrong PW; Ezekowitz JA; Zannad F; Ferreira JP; Coles A; Metra M; Voors AA; Califf RM; O'Connor CM; Mentz RJ
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004783. PubMed ID: 30354576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Kristensen SL; Jhund PS; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Cleland JGF; Carson PE; McMurray JJV
    JACC Heart Fail; 2015 Jun; 3(6):478-486. PubMed ID: 26046842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization.
    Suzuki S; Yoshihisa A; Sato Y; Kanno Y; Watanabe S; Abe S; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Ishida T; Takeishi Y
    J Am Heart Assoc; 2018 Sep; 7(17):e008316. PubMed ID: 30371158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.
    Tang WHW; Dupont M; Hernandez AF; Voors AA; Hsu AP; Felker GM; Butler J; Metra M; Anker SD; Troughton RW; Gottlieb SS; McMurray JJ; Armstrong PW; Massie BM; Califf RM; O'Connor CM; Starling RC
    JACC Heart Fail; 2015 Jan; 3(1):40-49. PubMed ID: 25453534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
    JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.